Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | -8.06% | -9.52% | +21.28% |
May. 15 | Atai Life Sciences N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Atai Life Sciences N.V. Announces CEO Changes | CI |
Financials (USD)
Sales 2024 * | 250K | Sales 2025 * | 250K | Capitalization | 286M |
---|---|---|---|---|---|
Net income 2024 * | -110M | Net income 2025 * | -150M | EV / Sales 2024 * | 940 x |
Net cash position 2024 * | 51.4M | Net cash position 2025 * | 137M | EV / Sales 2025 * | 598 x |
P/E ratio 2024 * |
-2.74
x | P/E ratio 2025 * |
-2.22
x | Employees | 83 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.9% |
Latest transcript on Atai Life Sciences N.V.
1 day | -8.06% | ||
1 week | -9.52% | ||
Current month | -13.64% | ||
1 month | -13.64% | ||
3 months | -7.07% | ||
6 months | +54.05% | ||
Current year | +21.28% |
Managers | Title | Age | Since |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 18-05-31 |
Srinivas Rao
FOU | Founder | 55 | 18-05-31 |
Anne Johnson
DFI | Director of Finance/CFO | 55 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 20-12-31 |
Founder | 45 | 18-05-31 | |
Amir Kalali
BRD | Director/Board Member | 58 | 22-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.71 | -8.06% | 2,357,197 |
24-05-16 | 1.86 | -9.27% | 1,491,697 |
24-05-15 | 2.05 | +7.33% | 1,659,103 |
24-05-14 | 1.91 | -1.55% | 398,703 |
24-05-13 | 1.94 | +2.65% | 427,254 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.28% | 286M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- ATAI Stock